Wednesday, July 01, 2015 3:29:05 PM
Dallas, TX – July 1st, 2015 – InvestorsHub News Wire -- ProTek Capital Inc. (OTCPK: PRPM).
Today, the company and its management would like to announce several updates:
The management filed the request for Dividends with FINRA. As of today’s filings, the dates are as follows;
1. Record date July 15th, (this is the date that determines what amount of shares are held by the
shareholders on July 15th, and therefore the dividend will be issues on a 20 to 1 ratio from the number of
shares held on record date, for every 20 shares of PRPM the shareholder will get 1 share of SUTI).
2. Payment/distribution date July 30th: (This is when the dividend is scheduled for payment)
3. Declaration Date July 1st: This is the date when this filing was announced to the public.
The management is currently waiting for the official approval from FINRA, which will follow by a Press Release
from both FINRA and then both the dividend receiving company, ProTek Capital Inc., (PRPM ) and the dividend
issuer SutimCo International Inc.
The management will continue with the follow up and updates on this and other company’s developments.
Recently, the company launched a new web portal: www.protkcapital.com .
Protek’s new site will keep investors and stakeholders aware of the latest developments of the company and
provide a professional information venue for all interested parties. Protek management feels that this step, is one
of many events planned to solidify the company’s presence and provide the utmost level of transparency, while
providing up-to-date information and releases concerning company developments.
The site also serves to showcase the development services of IncStocks, which is highlighted by their Investor
Relations Profile. The profile is a unique, dynamic investor portal, offering rich information driven access to state
of the art investor related data. The portal is powered by QuoteMedia, which is the industry leader in investment
data services.
http://www.otcmarkets.com/otciq/ajax/showNewsReleaseDocumentById.pdf?id=15688
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM